re: Ann: Clinuvel commences US Phase III tria... They're not known to.
The FDA will usually provide pharmas with a calendar date for the decision. You'll get a panel review date and a final decision date. The panel review will usually give an idea of which way the final decision will go.
However, it can get a little tricky even with the FDA approval date at times as they can sometimes slip in a decision a couple weeks beforehand and stun investors with some bad news who were holding waiting closer to the appointed calendar date. That's why many investors clear the deck about 2 weeks before the FDA decision date.
But, the FDA is much better at clarity on a decision date than the European regulators are. Playing biotechs / pharma stocks isn't recommended for those with a pacemaker.
- Forums
- ASX - By Stock
- Ann: Clinuvel commences US Phase III trial of SCE
re: Ann: Clinuvel commences US Phase III tria... They're not...
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CUV (ASX) to my watchlist
|
|||||
Last
$15.69 |
Change
0.280(1.82%) |
Mkt cap ! $785.7M |
Open | High | Low | Value | Volume |
$15.16 | $15.98 | $15.03 | $2.391M | 152.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1355 | $15.64 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.75 | 1783 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100 | 15.600 |
1 | 500 | 15.050 |
1 | 2853 | 15.030 |
2 | 1000 | 15.000 |
1 | 600 | 14.800 |
Price($) | Vol. | No. |
---|---|---|
15.750 | 1300 | 2 |
15.790 | 100 | 1 |
15.820 | 250 | 1 |
15.920 | 250 | 1 |
15.930 | 3000 | 1 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online